Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nykode Therapeutics | Oslo | Salute | Ricerca medica e biotecnologica | 1,52 Mrd NOK | -4,5x | -0,15 | 4,60 NOK | -0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Arcticzymes Tech | Oslo | Salute | Ricerca medica e biotecnologica | 910,09 Mln NOK | 63,2x | 41,48 | 17,82 NOK | 0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 36,1% Rialzo | Fai l’upgrade a Pro+ | |
Bergenbio | Oslo | Salute | Ricerca medica e biotecnologica | 395,56 Mln NOK | -1,9x | -0,03 | 10,12 NOK | 5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Lytix Biopharma AS | Oslo | Salute | Ricerca medica e biotecnologica | 364,14 Mln NOK | -4,3x | -0,24 | 6,92 NOK | -5,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Lifecare | Oslo | Salute | Ricerca medica e biotecnologica | 320,26 Mln NOK | -6,6x | 1,18 | 1,58 NOK | -3,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Thor Medical | Oslo | Salute | Ricerca medica e biotecnologica | 284,18 Mln NOK | -21,6x | 1,21 NOK | 4,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Exact Therapeutics AS | Oslo | Salute | Ricerca medica e biotecnologica | 184,46 Mln NOK | -4,6x | 0,26 | 5,75 NOK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
PCI Biotech | Oslo | Salute | Ricerca medica e biotecnologica | 67,19 Mln NOK | -4,2x | -0,09 | 1,80 NOK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Ultimovacs | Oslo | Salute | Ricerca medica e biotecnologica | 58,83 Mln NOK | -0,5x | -0,09 | 1,71 NOK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
SoftOx Solutions | Oslo | Salute | Ricerca medica e biotecnologica | 37,07 Mln NOK | -0,1x | -0,01 | 0,02 NOK | 1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Circio Holding | Oslo | Salute | Ricerca medica e biotecnologica | 17,16 Mln NOK | 0,6x | 0,02 | 0,70 NOK | -2,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |